| A study of typhoid fever in five Asian countries: disease burden and implications for controls RL Ochiai, CJ Acosta, MC Danovaro-Holliday, D Baiqing, ... Bulletin of the world health organization 86 (4), 260-268, 2008 | 889 | 2008 |
| A thermostable, closed SARS-CoV-2 spike protein trimer X Xiong, K Qu, KA Ciazynska, M Hosmillo, AP Carter, S Ebrahimi, Z Ke, ... Nature structural & molecular biology 27 (10), 934-941, 2020 | 279 | 2020 |
| The natural history and transmission potential of asymptomatic severe acute respiratory syndrome coronavirus 2 infection N Van Vinh Chau, VT Lam, NT Dung, LM Yen, NNQ Minh, LM Hung, ... Clinical Infectious Diseases 71 (10), 2679-2687, 2020 | 255 | 2020 |
| Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label … RW van Der Pluijm, R Tripura, RM Hoglund, AP Phyo, D Lek, A Ul Islam, ... The Lancet 395 (10233), 1345-1360, 2020 | 212 | 2020 |
| A current perspective on antimicrobial resistance in Southeast Asia RM Zellweger, J Carrique-Mas, D Limmathurotsakul, NPJ Day, ... Journal of Antimicrobial Chemotherapy 72 (11), 2963-2972, 2017 | 184 | 2017 |
| Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey KB Pouwels, T House, E Pritchard, JV Robotham, PJ Birrell, A Gelman, ... The Lancet Public Health 6 (1), e30-e38, 2021 | 180 | 2021 |
| Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial GE Thwaites, M Scarborough, A Szubert, E Nsutebu, R Tilley, J Greig, ... The Lancet 391 (10121), 668-678, 2018 | 177 | 2018 |
| Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal M Shakya, R Colin-Jones, K Theiss-Nyland, M Voysey, D Pant, N Smith, ... New England Journal of Medicine 381 (23), 2209-2218, 2019 | 161 | 2019 |
| A trial of itraconazole or amphotericin B for HIV-associated talaromycosis T Le, NV Kinh, NTK Cuc, NLN Tung, NT Lam, PTT Thuy, DD Cuong, ... New England Journal of Medicine 376 (24), 2329-2340, 2017 | 152 | 2017 |
| Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis LA Weinert, RR Chaudhuri, J Wang, SE Peters, J Corander, T Jombart, ... Nature communications 6 (1), 6740, 2015 | 151 | 2015 |
| An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid VK Wong, S Baker, TR Connor, D Pickard, AJ Page, J Dave, N Murphy, ... Nature communications 7 (1), 12827, 2016 | 146 | 2016 |
| Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a … BMC medicine 17, 1-20, 2019 | 145 | 2019 |
| GeneXpert MTB/Rif to diagnose tuberculous meningitis: perhaps the first test but not the last NC Bahr, S Marais, M Caws, R Van Crevel, RJ Wilkinson, JS Tyagi, ... Clinical Infectious Diseases 62 (9), 1133-1135, 2016 | 129 | 2016 |
| Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study CM Ndila, S Uyoga, AW Macharia, G Nyutu, N Peshu, J Ojal, M Shebe, ... The Lancet Haematology 5 (8), e333-e345, 2018 | 106 | 2018 |
| Open source clinical science for emerging infections JW Dunning, L Merson, GGU Rohde, Z Gao, MG Semple, D Tran, ... The Lancet. Infectious diseases 14 (1), 8, 2014 | 104 | 2014 |
| Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam A Fox, LNM Hoa, CP Simmons, M Wolbers, HFL Wertheim, PT Khuong, ... PLoS neglected tropical diseases 5 (3), e967, 2011 | 101 | 2011 |
| Standardized methods for enhanced quality and comparability of tuberculous meningitis studies BJ Marais, AD Heemskerk, SS Marais, R van Crevel, U Rohlwink, M Caws, ... Clinical Infectious Diseases 64 (4), 501-509, 2017 | 95 | 2017 |
| Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia GM Clarke, K Rockett, K Kivinen, C Hubbart, AE Jeffreys, K Rowlands, ... elife 6, e15085, 2017 | 85 | 2017 |
| Improving the estimation of the global burden of antimicrobial resistant infections D Limmathurotsakul, S Dunachie, K Fukuda, NA Feasey, IN Okeke, ... The Lancet infectious diseases 19 (11), e392-e398, 2019 | 84 | 2019 |
| Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... Cell Reports Medicine 1 (6), 2020 | 83 | 2020 |
